{"article_title": "What Big Pharma Could Learn From A Craft Beer Brewer", "article_keywords": ["pharma", "brewer", "big", "beer", "craft", "learn"], "article_url": "http://www.forbes.com/sites/brucejapsen/2014/06/21/what-big-pharma-could-learn-from-a-craft-beer-brewer/", "article_text": "", "article_metadata": {"description": "While U.S. companies like Pfizer (PFE), Walgreens (WAG) and Medtronic (MDT) make noise and grab political attention by looking at overseas domiciles to lower tax rates, along comes Tony Magee, brewer of the popular Lagunitas IPA from a different school of thought. He\u2019s headed to Chicago, the largest city in the [...]", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "While U.S. companies like Pfizer (PFE), Walgreens (WAG) and Medtronic (MDT) make noise and grab political attention by looking at overseas domiciles to lower tax rates, along comes Tony Magee, brewer of the popular Lagunitas IPA from a different school of thought. He\u2019s headed to Chicago, the largest city in the [...]", "title": "What Big Pharma Could Learn From A Craft Beer Brewer", "url": "http://www.forbes.com/sites/brucejapsen/2014/06/21/what-big-pharma-could-learn-from-a-craft-beer-brewer/", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/06/8062883771_6ef2dbbb49_b.jpg", "updated_time": "2014-06-22T12:51:29-04:00", "type": "article"}, "twitter": {"description": "While U.S. companies like Pfizer (PFE), Walgreens (WAG) and Medtronic (MDT) make noise and grab political attention by looking at overseas domiciles to lower tax rates, along comes Tony Magee, brewer of the popular Lagunitas IPA from a different school of thought. He\u2019s headed to Chicago, the largest city in the [...]", "creator": "@brucejapsen", "image": "http://blogs-images.forbes.com/brucejapsen/files/2014/06/8062883771_6ef2dbbb49_b.jpg", "title": "What Big Pharma Could Learn From A Craft Beer Brewer", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Powering Productivity,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy,Abbott Laboratories,Chicago,Chicago Sun-Times,Illinois,Internal Revenue Service,Lagunitas IPA,Medtronic,Pfizer,Rahm Emanuel,Walgreen", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2014-06-22", "published": "2014-06-21", "id": "blogAndPostId/blog/post/2125-7023"}, "news_keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Powering Productivity,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy,Abbott Laboratories,Chicago,Chicago Sun-Times,Illinois,Internal Revenue Service,Lagunitas IPA,Medtronic,Pfizer,Rahm Emanuel,Walgreen", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}